Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
IGF-1 C domain-modified nanoparticles (NP-IGF-1 C) promote Bcl-2 expression while activating the Akt/mTOR pathway through the binding of the IGF-1 C domain to renal tubular epithelial cell receptors, thereby inhibiting apoptosis and promoting cell proliferation, achieving a synergistic anti-apoptotic - pro-regenerative effect and significantly accelerating renal tubular repair
No compounded peptide formulations are not FDA-approved drug products and are categorically excluded from insurance coverage, including FSA and HSA reimbursement in most cases
Ozempic (a GLP-1 receptor agonist) works by mimicking a hormone that increases insulin production and decreases sugar production in the liver
Niacinamide rounds out the formula by correcting uneven skin tone and promoting a clearer, more luminous complexion
FDA-reviewed studies have evaluated these medications in their branded forms: Semaglutide showed an average weight reduction of ~15% over 68 weeks
A qualified healthcare provider should assess your metabolic history, current medications, kidney function, and individual risk factors before recommending any GLP-1 formulation
